News

Jennifer is a Partner at European venture capital firm, Seroba Life Sciences. She is based in the Dublin office and is involved in medtech and biotech deal origination and investments. After graduating from University College Dublin with an honours degree in Pharmacology, Jennifer entered a Master’s degree programme in Biotechnology and Business. Having placed first in her Master’s in 2011, Jennifer then joined Seroba as an Investment Analyst.

In 2019 Jennifer completed her Diploma in Company Direction, accredited by the Institute of Directors UK. She represents Seroba on the board of Endotronix, Palliare and Shorla Oncology (Observer). Previous Directorships include, Biosensia, prior to it merging with Kypha Diagnostics (2018), Observer on the Atlantic Therapeutics board and she managed the fund’s investment in Labcyte prior to its acquisition by Beckman Coulter (2019).

In 2015, Jennifer was recognized as one of Ireland’s ‘Top 30 Under 30’, shaping the future of business in the country. In 2019, she joined the Advisory Board for the European Healthcare Businesswoman’s Association (HBA) and in 2019 she established the Level20 Ireland Chapter, an international not-for-profit organisation promoting gender diversity in Private Equity and became International Chair of the 12 European Chapters in 2021. She was subsequently appointed to the Board of Level 20 (UK) in 2022.